CDT — CDT Equity Share News
0.000.00%
Last trade - 00:00Brief: Cdt Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
Brief: Cdt Equity Stockholders Approve All Proposals At Special Meeting, Positioning The Company For Next Phase Of Growth
Brief: CDT Equity Lowers Floor Price To $0.60 In Purchase Agreement Amendment On March 3, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Homebuilders, solar stocks, Alphabet
U.S. STOCKS ON THE MOVE-Comfort Systems, Funko, Paymentus
U.S. STOCKS ON THE MOVE-Deckers Outdoor, CDT Equity, Comfort Systems
CDT Equity rises after deal to buy 20% stake in UK AI firm Sarborg
Brief: CDT Equity Inc Buys 9.256 Bitcoin For $1,005,000
Brief: CDT Equity Buys 8.65 BTC For $1 Million
Brief: Cdt Equity Inc - Board Approves Cryptocurrency-Based Treasury Reserve Strategy
Brief: Conduit Pharmaceuticals Inc - To Change Name To Cdt Equity Inc.
Brief: Conduit Pharmaceuticals Files New Patent For AZD5904
Brief: Conduit Pharmaceuticals Files Prospectus To Offer Resale Of Up To 2.2 Mln Shares Of Common Stock By Selling Stockholders
Brief: Conduit Pharmaceuticals Announces Leadership Changes
Brief: Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For Vtama®
Brief: Conduit Pharmaceuticals Expands Partnership With Sarborg Limited
Brief: Conduit Pharmaceuticals Files For Offering Of Up To $17.8 Million Of Shares Of Common Stock - SEC Filing
Brief: Conduit Pharmaceuticals Partners With Charles River In Systemic Lupus Erythematosus Model
Brief: Conduit Pharmaceuticals Inc. Announces Reverse Stock Split